Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc.

13.48
EUR
-0.26
(-1.89%)
0.12EPS
130.48P/E
1.73BMarket Cap
Mar 03Next Earn

Sarepta Therapeutics, Inc. Documents

Q1 FY2021 · Presentation

Sarepta Therapeutics Inc - Study Result - Conference Call Deck · 26 pages

Read Sarepta Therapeutics, Inc.'s results firsthand

Preview the first 2 pages of this presentation
Create a free account to start reading

Full documents are included with Professional

Q1 FY2021 documents